Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alchimica is a Czech specialty chemicals and life-science ingredients company that distributes active pharmaceutical ingredients, pharmaceutical excipients, nutraceutical and food ingredients, cosmetic ingredients, laboratory reagents, and related specialty chemicals. The company appears to operate primarily as a commercial supplier and distributor rather than a drug developer, serving customers in pharmaceuticals, veterinary products, nutraceuticals, research, and industrial applications. Its website highlights a catalog of more than 60,000 substances for scientific, research, and development use, along with custom sourcing and custom synthesis capabilities. Alchimica also markets proprietary or branded ingredient offerings such as Purelium nutraceutical ingredients, Purelium Pearls Technology, Alchacet acetates, and Reagentia products. Based on the available evidence, the company is healthcare-related through its pharmaceutical, nutraceutical, and veterinary ingredient supply business, but it does not appear to run a clinical therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alchimica.